Menu
Not yet recruiting NCT06996873

Aggressive Spinal Hemangioma

Observational Aggressive Spinal Hemangiomas

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
This is an observational study: the protocol does not assign a study treatment.
Who it may be relevant to
Registry conditions: Aggressive Spinal Hemangiomas. Basic parameters: No limits · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
Center list to be confirmed — check the primary protocol.
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Official title

Management Of Aggressive Spinal Hemangioma

Overview

This research is a case series analysis to evaluate aggressive vertebral hemangiomas. It focuses on clinical presentation, diagnostic imaging accuracy (X-ray, MRI, MSCT, angiography), and treatment efficacy. The primary goal is to establish optimal management protocols.

Detailed description

Hybrid methodology integrating retrospective case reviews (from Assiut University Hospital's Orthopedic Surgery Department) with synthesis of existing literature.

Objectives:

Characterize clinical presentations and imaging findings. Compare diagnostic accuracy across modalities. Analyze treatment outcomes, including procedural success rates and complications.

Tools:

Imaging: X-ray for initial screening, MRI/MSCT for soft tissue and spinal cord involvement, angiography for vascular mapping.

Primary outcome measures

  • Neurological Symptom Resolution [Time frame: 3 months]
Secondary outcome measures (1)
  • Functional Status Improvement [Time frame: 3 months]

Eligibility criteria

Inclusion criteria

  • Patients diagnosed with aggressive spinal hemangiomas based on clinical symptoms and imaging findings.
  • Cases confirmed through diagnostic modalities such as X-ray, MRI, MSCT, or angiography.
  • Patients presenting with symptoms such as pain, neurological deficits, or spinal instability attributable to the hemangioma.

Exclusion criteria

  • Patients with incidentally discovered spinal hemangiomas (asymptomatic cases found during evaluations for unrelated conditions).
  • Cases lacking sufficient diagnostic evidence to confirm aggressive spinal hemangioma.

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Observational model
Cohort

Study locations

Center list to be confirmed — check the primary protocol.

Identifiers

NCT: NCT06996873 · Spinal Hemangioma mangement

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗